Displaying 20 results from an estimated 4000 matches similar to: "Sample size for factorial clinical trials with survival endpoints"
2004 Feb 05
2
Incomplete Factorial design
Hello,
I am planning a study with the main point to evaluate the interaction of two treatments,
but for ethical reasons one cell is empty, that with patients receaving no treatment at all
Treatment B
2006 Oct 04
0
[OT] Survival and Function as co-primary endpoints in clinical trials. How to simulate in R ?
Dear R-Helpers,
Apologies in advance as this is partly (widely ?) OT. Not sure where to
ask, R is my favorite computer tool (no kidding) and there are plenty of
knowledgable and helpful people on the list.
Background: There are discussions among experts and regulatory
authorities (cf guideline
http://www.emea.europa.eu/pdfs/human/ewp/056598en.pdf) that, in for
example Amyotrophic Lateral
2004 Nov 09
3
Strange results for Beta Distribution
Dear All,
I got these results from the example in the function "dbeta":
>x <- seq(0, 1, length=21)
> dbeta(x, 1, 1)
[1] 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Any Idea?
TIA
Giovanni
dr. Giovanni Parrinello
Section of Medical Statistics
Department of Biosciences
University of Brescia
25127 Viale Europa, 11
Brescia Italy
Tel: +390303717528
Fax: +390303701157
2008 Feb 07
1
Appell Hypergeometric function
Dear All,
I am looking for an implementation in R of the Appell Hypergeometric
function.
Any suggestions will be more than appreciated!
GP
--
dr. Giovanni Parrinello
External Lecturer
Medical Statistics Unit
Department of Biomedical Sciences
Viale Europa, 11 - 25123 Brescia Italy
Tel: +390303717528
Fax: +390303717488
email: parrinel at med.unibs.it
2007 Jun 08
6
"R is not a validated software package.."
Dear All,
discussing with a statistician of a pharmaceutical company I received
this answer about the statistical package that I have planned to use:
As R is not a validated software package, we would like to ask if it
would rather be possible for you to use SAS, SPSS or another approved
statistical software system.
Could someone suggest me a 'polite' answer?
TIA
Giovanni
--
dr.
2002 Nov 23
0
Library QVF from Carroll et al.
Dear All,
I am looking for the library QVF [ NONLINEAR MEASUREMENT ERROR PROGRAMS FOR
SAS AND SPLUS ].
TIA
Giovanni Parrinello
dr. Giovanni Parrinello
Medical Statistics Unit
Department of Medical Sciences
University of Brescia
Via Valsabbina, 19
25127 Brescia
Italy
tel.: +39303717528
fax:+39303701157
E-mail: parrinel at med.unibs.it
url: http://www.med.unibs.it/dip/stat/index.html
2006 Jan 18
2
Loading of namespace on load of .Rdata (was strange behaviour of load)
Last week Giovanni Parrinello posted a message asking why various packages were loaded when he loaded an .Rdata file. Brian Ripley replied saying he thought it was because the saved workspace contained a reference to the namespace of ipred. (Correspondence copied below).
This begs the question: how did the reference to the namespace of ipred come to be in the .Rdata file? Brian did say it is
2006 Jan 18
0
Loading of namespace on load of .Rdata (was strange behaviour of load)
Last week Giovanni Parrinello posted a message asking why various packages were loaded when he loaded an .Rdata file. Brian Ripley replied saying he thought it was because the saved workspace contained a reference to the namespace of ipred. (Correspondence copied below).
This begs the question: how did the reference to the namespace of ipred come to be in the .Rdata file? Brian did say it is
2006 Nov 30
1
update.packages
Dear All,
from some days when I try to update the installed packages I receive
this answer:
update.packages(ask='graphics')
--- Please select a CRAN mirror for use in this session ---
Error in as.list(read.dcf(file = file)[1, ]) :
indice fuori limite # index out of bound
TIA
Giovanni
PS: I have already tried to solve the problem reinstalling R or changing
the options of
2006 Sep 22
1
Propensity score and three treatments
Dear All,
I would like to find something ( references, code,..) to implement a
comparison of three
treatments in an observational study using the 'Propensity Score'.
Any help is much appreciated. Thanks!
Giovanni
--
dr. Giovanni Parrinello
Department of Biotecnologies
Medical Statistics Unit
University of Brescia
Viale Europa, 11 25123 Brescia
email: parrinel at med.unibs.it
Phone:
2007 Jan 05
1
Error in load
Dear All,
can anyone explain this message
Error in load("matched2.RData") : Value of SET_STRING_ELT() must be a
'CHARSXP' not a 'builtin'?
Have I the possibility to retrieve the data?
TIA
Giovanni
--
dr. Giovanni Parrinello
Department of Biotecnologies
Medical Statistics Unit
University of Brescia
Viale Europa, 11 25123 Brescia
email: parrinel at med.unibs.it
Phone:
2009 Jan 14
1
problems with Sweave and the function latex(HMISC)
latex(s6a2,title="",caption="Baseline vs
zonr",file="",label="Base",long=TRUE,landscape=F, middle.bold=TRUE,here=T,
+
,size="smaller[5]",outer.size="smaller",Nsize="smaller",midsize="smaller")
"latex" is not reconized \as a internalor external command ,
un programma eseguibile o un file batch.
Warning
2010 Feb 19
1
BMDP and SAS (was R in clinical trials)
I used both BMDP and SAS in my earlier years, side by side. At that
time the BMDP statistical methods were much more mature and
comprehensive: we treated them as the standard when the two packages
disagreed. (It was a BMDP manual that clearly explained to me what the
hypothesis of "Yate's weighted mean test" is, something SAS decided to
call "type III" and eternally
2010 Apr 27
1
Randomization for block random clinical trials
Hi,
I’m new to R (just installed today) and I’m trying to figure out how to do
stratified randomisation using it. My google search expedition has lead me
to believe that blockrand package will most probably be the answer to it.
I’ve played around with blockrand for awhile and tried the sample code:
library(blockrand)
##stratified by sex
male <- blockrand(n=100,
2009 Jan 11
2
R, clinical trials and the FDA
I hope that Marc doesn't mind, but I felt that part of his recent post
was important enough to deserve it's own subject line rather then
being lost in a 60-msg-long thread...
On Sun, Jan 11, 2009 at 10:08 AM, Marc Schwartz
<marc_schwartz at comcast.net> wrote:
...
I strongly believe that the comments regarding R and the FDA are overly
negative and pessimistic.
The hurdles to
2009 Dec 17
2
SPLUS Seqtrial vs. R Packages for sequential clinical trials designs
Hello Everyone,
I’m a SAS user who has recently become interested in sequential clinical trials designs. I’ve discovered that the SAS based approaches for these designs are either too costly or are “experimental.” So now I’m looking for alternative software. Two programs that seem promising are SPLUS Seqtrial and R.
I recently obtained a 30 day trial for the SPLUS Seqtrial add-on and have
2005 Nov 30
3
Random Effects for One-Way Anova
Hello to All.
I'd want to use a one-way ANOVA. This means that I have only one factor, with,
lets say, 5 levels.
I made a dataframe, called "DATA", with two Columns:
A, that is my response, and it is "class numerical".
B, that defines the different levels of my factor, and it is "class factor".
If I want to use a fixed effect model,
I know that the formula I have
2011 Oct 29
1
How to plot survival data from multiple trials (simulations)?
Dear all:
Could anyone please provide some R codes to plot the below survival data to compare two groups (0 vs 1) after 2 simulations (TRL)? need 95% prediction interval on the plot from these 2 trials. I would like to simulate 1000 trials later. Thanks a lot for your great help and consideration!
yan
TRL ID ECOG BASE PTR8 GROUP POP ST ind
1 1 1 1 2.2636717 0.255634126 1 1 99.4 F
3 1 2 1
2010 Feb 17
8
Use of R in clinical trials
Dear all,
There have been a variety of discussions on the R list regarding the use of R in clinical trials. The following post from the STATA list provides an interesting opinion regarding why SAS remains so popular in this arena: http://www.stata.com/statalist/archive/2008-01/msg00098.html
Regards,
-Cody Hamilton
2008 May 12
4
Left censored responses in mixed effects models
Dear R Fellow-Travellers:
What is your recommended way of dealing with a left-censored response
(non-detects) in (linear Gaussian) mixed effects models?
Specifics: Response is a numeric positive measurement (of volume, actually);
but when it falls below some unknown and slightly random value (depending on
how the sample is prepared and measured), it cannot be measured and is
recorded as 0.